MarketsSingle-source
2.0
Outlook Therapeutics reports executive or director departure via 8-K filing
SEC EDGAR 8-K FilingsLO·US·about 9 hours ago
Titan Acquisition Corp. has submitted an 8-K filing to the SEC containing a Regulation FD disclosure and associated financial exhibits. The filing indicates a material event or information release intended for public dissemination, though specific details regarding the nature of the disclosure are not provided in the summary metadata.